Kliničke studije za Мигрена u državi Nebraska
10 studija za Мигрена traži učesnike na lokacijama u državi Nebraska.
Gradovi u državi Nebraska
Zvanični tekst studije (na engleskom)
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
Тражи се учесникФаза 4
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06972056Study of EVO756 in Adults With Migraine
- Papillion Research Center - Avacare Clinical Research, Papillion
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 11. 2026. · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Velocity Clinical Research, Norfolk, Norfolk
- Quality Clinical Research, Inc., Omaha
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07816367Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05156398A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06810505A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
Тражи се учесникФаза 1
Узраст од 6 до 11 · Оба пола · Ажурирано 28. 9. 2026. · NCT06995729Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 10. 2. 2026. · NCT07310290Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.